BCMA-Directed Therapy in Multiple Myeloma: Assessing the Clinical Impact
Our panel of myeloma experts highlight the BCMA antigen and its role as a therapeutic target in multiple myeloma.
Credit available for this activity expires: 2/18/2023
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/968684?src=mkm_podcast_addon_968684
Create your
podcast in
minutes
It is Free